LifeLink® of Florida Selects CompuMed Enterprise OPO Solution

Aug 18, 2015, 09:00 ET from CompuMed

LOS ANGELES, August 18, 2015 /PRNewswire/ --

LifeLink of Florida has selected CompuMed, Inc.'s (OTCPink: CMPD) Enterprise Organ Procurement Organization (OPO) Solution to improve donor organ recovery, and has begun the initial rollout of the CompuMed solution for 24/7, STAT echocardiogram interpretations and image sharing.

"CompuMed has been very helpful, and is an easy to work with solution that provides the necessary information required for transplant surgeons to determine if an organ is suitable for transplantation," stated Liz Lehr, Senior Vice President/Executive Director, LifeLink of Florida.

"The selection and rollout of CompuMed Enterprise OPO by a top organ procurement organization, such as LifeLink, further validates the benefits of our solution. We look forward to continuing to collaborate with LifeLink to support their mission of saving lives," said W. Scott Rombach, CompuMed's President and CEO.

CompuMed Enterprise OPO enables organ procurement organizations to save lives and increase organ yield through an end-to-end solution that includes 24/7, real-time interpretations of diagnostic exams and critical care consulting by CompuMed's Board-Certified specialists. By having near immediate access to CompuMed's team of specialists, OPOs are able to compress case times which results in improved efficiencies and cost savings. Through CompuMed image sharing technology, OPOs can more quickly provide diagnostic exam images to transplant surgeons, which improve the time to intervention.

CompuMed, in collaboration with West Coast Ultrasound Institute (WCUI), also delivers a course that trains OPO transplant coordinators in the administration of echocardiogram studies. The course enables OPOs to bring the sonography function in-house, with results in more timely clinical intervention and promotes increased organ yield.

Information on CompuMed's Enterprise OPO Solution is provided at

About CompuMed, Inc. 

CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world.  The company has been in business over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at

Forward-Looking Statements  

Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.

CompuMed, Inc. Investor Relations can be reached at or (310) 258-5000 x117.